Hemanext Archives

Hemanext AABB 2021

Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts center on the study of hypoxically stored red blood cells (RBCs). Learn More...

Hemanext Announces that Hypoxic Blood Storage Study has been Recognized as Best Original Research Paper by AABB

Hemanext, Press Release

Research supports Hemanext’s aim to improve clinical outcomes of transfusion recipients with its innovative red blood cell processing and storage system. LEXINGTON, Mass., September 21, 2021, PR NEWSWIRE – Hemanext Inc. (“Hemanext” or the...

Hemanext Announces Appointment of Paul M. Ness, M.D., to Board of Directors

Hemanext, Press Release

Senior Director of Transfusion Medicine at Johns Hopkins University Brings Global Experience in Transfusion Medicine and Research Company Recently Received CE Mark Certification for Innovative Red Blood Cell Processing and Storage System LEXINGTON, Mass., Aug 3, 2021,...

Hemanext Partners with Sickle Cell 101 to Sponsor Sickle Cell Education

Hemanext, Press Release

Sickle Cell Disease (SCD) Affects Over 20M Worldwide, including 100K Americans1,2 LEXINGTON, MA and SAN FRANCISCO, CA – Jul 28, 2021 – Hemanext Inc. a privately held, US-based medical technology company dedicated to improving the quality, safety, efficacy, and cost of...

Connect with Hemanext at ISBT 2020

Events, Hemanext, ISBT2020, News

Connect with Hemanext virtual booth at the 36th International Congress of Society of Blood Transfusions (ISBT). Learn about: Blood quality and potential impact on transfusion outcomes Potential benefits of hypoxic storage Hemanext’s vision to create a world with...

Celebrating Jimmy Devarie Conde (1969 – 2020)

Hemanext, News

In Commemoration of Jimmy Devarie Conde (1969 – 2020) With deep sadness, we inform you of the sudden passing on November 5th of Jimmy Devarie, Plant Manager of the NHS Manufacturing facility. Jimmy was admired, respected, and loved by his team and colleagues here at...

YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE

Hemanext AABB 2021

Hemanext Announces that Hypoxic Blood Storage Study has been Recognized as Best Original Research Paper by AABB

Hemanext Announces Appointment of Paul M. Ness, M.D., to Board of Directors

Hemanext Partners with Sickle Cell 101 to Sponsor Sickle Cell Education

Connect with Hemanext at ISBT 2020

Celebrating Jimmy Devarie Conde (1969 – 2020)

Recent Posts

Privacy